Neurocrine Biosciences (0K6R.L) Stock Price
$136.1 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
7 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences' financial performance has been somewhat mixed. The company reported a decrease in revenue by -8.8% from the previous quarter and down by -3% year over year, standing at $572.6M. Gross profit was also down both quarterly (-8.9%) and yearly (-1.9%), reaching $563.4M. Operating income took a significant hit, decreasing by -83.4% from the previous quarter and an alarming -84% year over year to $23.6M, indicating potential issues with operational efficiency or increased costs.
Stock Price
The stock price is currently at $136.07, up by 1% in the last month but down by -10.8% on a yearly basis which indicates some volatility in the stock's performance over time.The PE ratio is high at 186.40 suggesting that investors have high expectations of future earnings growth from Neurocrine Biosciences.The Relative Strength Index (RSI) stands at 62.9, which suggests that the stock is neither overbought nor oversold.
Alternative Data Signals
The company's web traffic shows promising signs with an increase of 46% month-over-month and a rise of 15.9% year-over-year indicating growing interest in their operations or products.Job postings are down both monthly and yearly (-13%), which could suggest either reduced hiring needs or cost-cutting measures.Employee sentiment seems positive as indicated by an estimated 82% reporting a positive business outlook despite slight decreases month-over-month and year-over-year.Social media audience growth on Twitter (26%) and Facebook (169%) indicate increasing brand awareness or engagement.
Conclusion
Overall, the analysis is neutral towards Neurocrine Biosciences' stock. While there are some positive indicators such as increased web traffic and social media engagement, these are somewhat offset by the decrease in revenue, gross profit and particularly operating income. The stock's high PE ratio suggests that investors have high expectations of future earnings growth from Neurocrine Biosciences which may put pressure on the company to deliver.
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $136.1, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
13.5B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.15 0.5% |
6 |
News
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 38210 monthly visitors to neurocrine.com.
-
Web Traffic
38210
-
Change from Previous Month
46%
-
3 Month Change
105.5%
-
YoY Change
105.5%
Twitter Followers
Neurocrine Biosciences has 789 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.1% over the last month.
-
Twitter Followers
789
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
6.3%
-
YoY Change
6.3%
Facebook Engagement
Neurocrine Biosciences has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
37.5%
-
1 Month Change
10%
-
3 Month Change
8.3%
-
YoY Change
8.3%
Job Postings
Neurocrine Biosciences has an estimated 70 open job postings, which is down -13.6% over the last month.
-
Job Postings
70
-
Daily Change
2.8%
-
1 Month Change
13.6%
-
3 Month Change
11.4%
Reddit Mentions
Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
78,213 are following Neurocrine Biosciences on LinkedIn, up by 2.5% over the last month.
-
LinkedIn Followers
78213
-
Daily Change
2.5%
-
1 Month Change
2.5%
-
3 Month Change
6.9%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,984 employees, up by 1.3% over the last month.
-
LinkedIn Employees
1984
-
Daily Change
1.3%
-
1 Month Change
1.3%
-
3 Month Change
4.6%
-
YoY Change
4.6%
Business Outlook
According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 82 out of 100 (very bullish).
-
Business Outlook
82
-
Change from Previous Month
1.2%
-
3 Month Change
1.2%
-
YoY Change
1.2%
News Mentions
Neurocrine Biosciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$572.6M
-
Net Income
$7.9M
-
Earnings per Share
$0.08
-
Free cash flow
$54.1M
-
EBITDA
$23.6M
-
EBITDA Ratio
0.0412155
-
Total Assets
$3.7B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $136.1.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 13.5B.
Should I buy or sell 0K6R.L?
Multiple alternative data signals suggest that Neurocrine Biosciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Neurocrine Biosciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Neurocrine Biosciences stock. The bullish indicators suggest that Neurocrine Biosciences' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Neurocrine Biosciences (0K6R.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Neurocrine Biosciences stock, given the bullish outlook.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Walgreens Boots Alliance and Esperion Therapeutics.
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $149.5 in 2026. Starting from the current price of $136.1, this represents a 9.8% change in price, indicating a bullish outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.